A Chat with Bernie Iliakis of CorneaGen

Bernie Iliakis, president and CEO of CorneaGen, discusses the growing momentum of CTAK to treat keratoconus, how the company is meeting the growing demand for DMEK and DSAEK tissue processing, and more.

November 1, 2025
4 min

Ophthalmology Management

At a Glance

Category	Detail
Condition
Key Mechanisms	CTAK utilizes custom tissue inlays for contouring keratoconic eyes, significantly improving visual acuity.
Target Population
Care Setting

Key Highlights

clinical_trials

Guideline-Based Recommendations

Diagnosis

Management

Utilize CTAK for surgical intervention in keratoconus patients.
Consider other management options such as corneal cross-linking or traditional grafting techniques.

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Individuals diagnosed with keratoconus.

CTAK provides a tailored approach to corneal grafting, enhancing surgical outcomes.

Clinical Best Practices

Employ custom tissue inlays for improved surgical precision.
Utilize preloaded DSAEK and DMEK tissue to save OR time and enhance tissue quality, as highlighted in the context.